Incidental Adrenal Mass Evaluation (ACR)
Incidental Adrenal Mass Evaluation (ACR): Incidental Adrenal Mass → Known Primary Malignancy? → Staging Workup.
Interactive Decision Tree
Algorithm Steps
- ▶Start
Incidental Adrenal Mass
Discovered on CT/MRI for unrelated indication
- ◆Decision
Known Primary Malignancy?
- Yes - staging workup
- No - characterize
- ●Action
Staging Workup
PET/CT, consider biopsy for treatment planning
- ◆Decision
CT Attenuation (Unenhanced)?
- ≤10 HU (lipid-rich)
- 10-30 HU
- >30 HU
- ●Action
Likely Benign Adenoma
≤10 HU highly specific for lipid-rich adenoma
- ◆Decision
Size Assessment
- <4cm - observe
- ≥4cm - surgery consult
- ■End
Annual Imaging x 1-2 Years
Consider biochemical workup
- ■End
Consider Adrenalectomy
If growth or hormonal symptoms
- ●Action
Washout CT or MRI
APW >60% or RPW >40% suggests adenoma
- ●Action
PET/CT or Biopsy
PET if known malignancy; biopsy if isolated
- ●Action
Suspicious Features
>30 HU, no washout, irregular margins
Guideline Source
ACR Appropriateness Criteria: Incidentally Discovered Adrenal Mass
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Does not address functional tumors in detail
- Biochemical workup recommendations vary by institution
- Size thresholds may differ internationally
Applicable Regions
EU: ENSAT guidelines with emphasis on functional screening
US: Endocrine Society recommends biochemical screen for all
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Incidental Adrenal Mass Evaluation (ACR)?
The Incidental Adrenal Mass Evaluation (ACR) is a diagnostic clinical algorithm for Radiology. It provides a structured decision tree to guide clinical decision-making, based on ACR Appropriateness Criteria: Incidentally Discovered Adrenal Mass.
What guideline is the Incidental Adrenal Mass Evaluation (ACR) based on?
This algorithm is based on ACR Appropriateness Criteria: Incidentally Discovered Adrenal Mass (DOI: 10.1016/j.jacr.2017.02.016).
What are the limitations of the Incidental Adrenal Mass Evaluation (ACR)?
Known limitations include: Does not address functional tumors in detail; Biochemical workup recommendations vary by institution; Size thresholds may differ internationally. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Incidental Adrenal Mass Evaluation (ACR) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free